CommercialPrior AuthHigh impact
Obstructive Sleep Apnea in Adults (CPB 0004, reviewed 2026-07-21)
Aetna·Sleep Medicine, Pulmonology, Internal Medicine +1 more·Medical Policy
Effective date
Jul 21, 2026
We identified it
Aug 12, 2026
Summary
Aetna has updated its comprehensive Clinical Policy Bulletin 0004 for Obstructive Sleep Apnea in Adults (reviewed 2026-07-21), establishing clear medical necessity criteria for diagnostic testing (attended polysomnography vs. home sleep studies), CPAP/BiPAP treatment authorization, and repeat testing protocols. The policy defines specific comorbid conditions, device types, and clinical indications that determine whether in-lab testing or home-based studies are appropriate, directly impacting which diagnostic codes can be billed and what prior authorization documentation is required.
Action Required
By 2026-07-21: Billing and clinical teams must implement the following changes: (1) Update billing software and prior authorization workflows to enforce Aetna's medical necessity criteria for sleep study authorization—specifically to require attended NPSG (Type I) only when documented comorbidities (e.g., moderate-severe COPD, CHF NYHA III/IV, BMI >45, neuromuscular disease) or other specified criteria are present; otherwise default to home sleep studies (Type II, III, IV(A), or Watch-PAT devices); (2) Modify prior authorization request templates to require documentation of specific comorbid conditions and AHI thresholds per the policy (e.g., AHI >15 for split-night studies, AHI ≤15 requiring full-night titration study); (3) Train providers and front-desk staff to add comorbidity verification and BMI/clinical indicators to sleep study intake forms; (4) Update denial protocols to reject claims for attended NPSG lacking documented comorbid indications, and reject home sleep studies using devices that do not measure AHI or oxygen saturation (e.g., SleepMinder, SNAP with <3 channels); (5) Implement repeat sleep study authorization limits (up to twice yearly) with interrogation of PAP device settings as a prerequisite in billing software; (6) Remove coverage for treatment of snoring alone without significant OSA from authorization templates. Failure to comply will result in claim denials and recoupment of inappropriately authorized services.